OS Therapies, Inc. raised $6 million in a private placement to support the commercialization of its therapeutic candidate OST-HER2 for metastatic osteosarcoma.
OS Therapies, Inc. raised $6 million in a private placement to support the commercialization of its therapeutic candidate OST-HER2 for metastatic osteosarcoma.
12/31/24, 8:41 PM
Location
rockvilleMoney raised
$6 million
Industry
health care
OS Therapies, Inc. has successfully closed a private placement financing, raising approximately $6 million. The funds will be used for working capital focused on clinical and regulatory milestones for their lead therapeutic candidate OST-HER2.
Company Info
Location
15825 shady grove road
rockville, maryland, united states
Additional Info
OS Therapies is a clinical stage research company focusing on therapeutic treatments for Osteosarcoma, Breast Cancer and other solid tumors with two platform technologies: OST-HER2 to prevent metastasis and OST-tADC to debulk solid tumors.